Fistula News and Research

RSS
A Fistula is an abnormal opening or passage between two organs or between an organ and the surface of the body. Fistulas may be caused by injury, infection, or inflammation, or may be created during surgery.
Therapeutic endoscopy has an expanding role in the treatment of IBD

Therapeutic endoscopy has an expanding role in the treatment of IBD

Non-surgical fistula creation system Ellipsys becomes key focus of attention at CiDA

Non-surgical fistula creation system Ellipsys becomes key focus of attention at CiDA

Study finds link between Medicaid expansion and lower death rates among dialysis patients

Study finds link between Medicaid expansion and lower death rates among dialysis patients

New approach using 'cellular dust' offers hope for regenerative medicine

New approach using 'cellular dust' offers hope for regenerative medicine

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

FDA grants marketing authorization for use of two catheter-based devices in hemodialysis patients

FDA grants marketing authorization for use of two catheter-based devices in hemodialysis patients

New tool gives hope for women with fistula injuries

New tool gives hope for women with fistula injuries

FDA authorizes marketing of Hemospray device for treating GI bleeding

FDA authorizes marketing of Hemospray device for treating GI bleeding

Opioid pain medications may not be safe for hemodialysis patients

Opioid pain medications may not be safe for hemodialysis patients

Researchers discover link between hypothyroidism and wound healing complications

Researchers discover link between hypothyroidism and wound healing complications

Study highlights risks involved in short-term use of PICCs

Study highlights risks involved in short-term use of PICCs

New biomarker may indicate success of popular treatment for atrial fibrillation

New biomarker may indicate success of popular treatment for atrial fibrillation

Report highlights risk of severe injuries caused by swallowed button batteries from 'fidget spinners'

Report highlights risk of severe injuries caused by swallowed button batteries from 'fidget spinners'

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.